Metagenomi Therapeutics (MGX) director receives 21,000-share stock option grant at $1.23
Rhea-AI Filing Summary
Metagenomi Therapeutics director Eric Bjerkholt received a grant of stock options covering 21,000 shares of common stock. The options have an exercise price of $1.23 per share and give the right to buy 21,000 shares once vested.
The options vest and become exercisable on the earlier of the one-year anniversary of the grant date or the company’s 2027 annual meeting of stockholders, provided he continues serving the company through that vesting date. Following this grant, his reported holdings of this option award total 21,000 derivative securities.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
BJERKHOLT ERIC
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 21,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 21,000 shares (Direct)
Footnotes (1)
- F1. The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date.
Key Figures
Option grant size: 21,000 shares
Exercise price: $1.23 per share
Underlying shares: 21,000 shares
+2 more
5 metrics
Option grant size
21,000 shares
Stock Option (Right to Buy) granted to director
Exercise price
$1.23 per share
Conversion or exercise price of stock option
Underlying shares
21,000 shares
Common Stock underlying the option grant
Post-grant option holdings
21,000 options
Total derivative securities following transaction
Option expiration
June 8, 2036
Expiration date of granted stock options
Key Terms
Stock Option (Right to Buy), exercise price, Grant, award, or other acquisition, annual meeting of stockholders, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 1.2300"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
annual meeting of stockholders financial
"the date of the Company's 2027 annual meeting of stockholders"
vest and become exercisable financial
"The shares subject to this option shall vest and become exercisable upon the earlier of"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Metagenomi Therapeutics (MGX) report for Eric Bjerkholt?
Metagenomi Therapeutics reported a stock option grant to director Eric Bjerkholt. He received options covering 21,000 shares of common stock at an exercise price of $1.23 per share, increasing his derivative-based exposure to the company’s stock.
What is the exercise price of Eric Bjerkholt’s Metagenomi (MGX) stock options?
The stock options have an exercise price of $1.23 per share. This means he can buy Metagenomi common shares at $1.23 once the options vest and are exercised, regardless of the market price at that time.
When do Eric Bjerkholt’s Metagenomi (MGX) stock options vest?
The options vest on the earlier of two dates. They become exercisable on the one-year anniversary of the grant date or on the date of Metagenomi’s 2027 annual meeting of stockholders, assuming his continued service through that vesting date.
Is Eric Bjerkholt’s Metagenomi (MGX) option grant an open-market purchase or compensation award?
The transaction is a compensation-related stock option award, not an open-market purchase. It is reported with code “A” as a grant or award acquisition and carries an exercise price of $1.23 per share for 21,000 underlying shares.
How many Metagenomi (MGX) stock options does Eric Bjerkholt hold after this grant?
After this grant, his reported holdings for this option award total 21,000 derivative securities. These options each relate to one share of common stock and are held directly, subject to the vesting terms described in the footnote.